Sphera Funds Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-86,094	Closed	-$1.96M	–	125
2024 Q3	$1.96M	Buy	+86,094	New	+$1.96M	0.31%	79
2021 Q1	–	Sell	-30,497	Closed	-$502K	–	192
2020 Q4	$502K	Buy	+30,497	New	+$502K	0.04%	98